DK1543063T3 - Medikament levering - Google Patents

Medikament levering

Info

Publication number
DK1543063T3
DK1543063T3 DK03748273T DK03748273T DK1543063T3 DK 1543063 T3 DK1543063 T3 DK 1543063T3 DK 03748273 T DK03748273 T DK 03748273T DK 03748273 T DK03748273 T DK 03748273T DK 1543063 T3 DK1543063 T3 DK 1543063T3
Authority
DK
Denmark
Prior art keywords
drug delivery
relates
delivery
drugs
solubilising
Prior art date
Application number
DK03748273T
Other languages
English (en)
Inventor
Ijeoma Uchegbu
Andreas Schatzlein
Woei Ping Cheng
Original Assignee
Univ London Pharmacy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London Pharmacy filed Critical Univ London Pharmacy
Application granted granted Critical
Publication of DK1543063T3 publication Critical patent/DK1543063T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • C08G73/0213Preparatory process
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • C08G73/0213Preparatory process
    • C08G73/0226Quaternisation of polyalkylene(poly)amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03748273T 2002-09-20 2003-09-22 Medikament levering DK1543063T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0221942.6A GB0221942D0 (en) 2002-09-20 2002-09-20 Drug delivery
PCT/GB2003/004036 WO2004026941A1 (en) 2002-09-20 2003-09-22 Drug delivery

Publications (1)

Publication Number Publication Date
DK1543063T3 true DK1543063T3 (da) 2009-05-18

Family

ID=9944516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03748273T DK1543063T3 (da) 2002-09-20 2003-09-22 Medikament levering

Country Status (11)

Country Link
US (1) US20060148982A1 (da)
EP (1) EP1543063B1 (da)
JP (1) JP2006500437A (da)
AT (1) ATE426635T1 (da)
AU (1) AU2003267581A1 (da)
CA (1) CA2499681A1 (da)
DE (1) DE60326859D1 (da)
DK (1) DK1543063T3 (da)
GB (1) GB0221942D0 (da)
SI (1) SI1543063T1 (da)
WO (1) WO2004026941A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422877D0 (en) * 2004-10-14 2004-11-17 Univ Glasgow Bioactive polymers
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
EA025295B1 (ru) 2006-01-19 2016-12-30 Элексел, Инк. Амфифильные гребенчатые полимеры, фармацевтическая композиция и способы повышения растворимости веществ
CN101374885A (zh) * 2006-01-27 2009-02-25 西巴控股公司 聚合物抗微生物剂
CA2670749A1 (en) * 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US20090263346A1 (en) * 2006-12-05 2009-10-22 David Taft Systems and methods for delivery of drugs
US20090246155A1 (en) * 2006-12-05 2009-10-01 Landec Corporation Compositions and methods for personal care
US20100004124A1 (en) * 2006-12-05 2010-01-07 David Taft Systems and methods for delivery of materials for agriculture and aquaculture
US8399007B2 (en) * 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
EP2126020B1 (de) * 2006-12-22 2011-11-23 Basf Se Hydrophob modifizierte polyalkylenimine als farbübertragungsinhibitoren
US9770442B2 (en) * 2007-07-19 2017-09-26 Allexcel Inc. Self-assembling amphiphilic polymers as anti-cancer agents
US8114883B2 (en) * 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
GB0903559D0 (en) 2009-03-02 2009-04-08 Univ London Pharmacy Oral delivery of hydrophilic drugs to the brain
EP2424581B1 (en) 2009-04-28 2017-03-01 SurModics, Inc. Devices and methods for delivery of bioactive agents
GB0915449D0 (en) 2009-09-04 2009-10-07 Univ Robert Gordon Composition
CA3000077A1 (en) * 2010-04-28 2011-11-10 University Of Georgia Research Foundation, Inc. Photochemical cross-linkable polymers, methods of making photochemical cross-linkable polymers, methods of using photochemical cross-linkable polymers, and methods of making articles containing photochemical cross-linkable polymers
US8721936B2 (en) 2011-04-21 2014-05-13 University Of Georgia Research Foundation, Inc. Devices and methods for forming non-spherical particles
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
CA2841000C (en) 2011-07-15 2020-02-25 University Of Georgia Research Foundation, Inc. Permanent attachment of agents to surfaces containing c-h functionality
WO2013019918A2 (en) 2011-08-04 2013-02-07 The University Of Georgia Research Foundation, Inc. Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing-oh functionality
WO2013056007A2 (en) 2011-10-14 2013-04-18 University Of Georgia Research Foundation, Inc. Photochemical cross-linkable polymers, methods of making photochemical cross-linkable plolymers, methods of using photochemical cross-linkable poloymers, and methods of making articles containing photochemical cross-linkable polymers
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
CA2890205C (en) * 2012-11-05 2020-12-22 Surmodics, Inc. Composition and method for delivery of hydrophobic active agents
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
JP2021065776A (ja) * 2021-02-04 2021-04-30 株式会社三洋物産 遊技機

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US5681543A (en) * 1988-02-29 1997-10-28 Shering Aktiengesellschaft Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
JPH01236240A (ja) * 1989-01-14 1989-09-21 Miyoshi Oil & Fat Co Ltd 新規な高分子化合物
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
JP3406970B2 (ja) * 1993-12-27 2003-05-19 ミヨシ油脂株式会社 両性界面活性剤
JP3526661B2 (ja) * 1995-06-23 2004-05-17 ミヨシ油脂株式会社 抗菌剤、抗菌性樹脂及び抗菌性塗料
EP0912493A1 (en) * 1996-06-19 1999-05-06 The Procter & Gamble Company Process for removing malodors from modified polyamines
CA2321200A1 (en) * 1998-02-27 1999-09-02 Dnavec Research Inc. Composition for transporting negatively charged substances
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
AU2001289943A1 (en) * 2000-10-09 2002-04-22 Bayer Aktiengesellschaft Complexes for transferring nucleic acids into cells
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
GB0221941D0 (en) * 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps

Also Published As

Publication number Publication date
WO2004026941A1 (en) 2004-04-01
ATE426635T1 (de) 2009-04-15
DE60326859D1 (de) 2009-05-07
AU2003267581A8 (en) 2004-04-08
JP2006500437A (ja) 2006-01-05
SI1543063T1 (sl) 2009-08-31
CA2499681A1 (en) 2004-04-01
US20060148982A1 (en) 2006-07-06
EP1543063A1 (en) 2005-06-22
GB0221942D0 (en) 2002-10-30
EP1543063B1 (en) 2009-03-25
AU2003267581A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
DK1543063T3 (da) Medikament levering
CY1118496T1 (el) Φαρμακεyτικες συνθεσεις
CY1118179T1 (el) Φαρμακευτικη συνθεση
CY1112946T1 (el) 4-υδροξυβενζομορφανια
BRPI0514293A (pt) sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga
CY1111458T1 (el) Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
EA200301250A1 (ru) Фармацевтические композиции, содержащие слаборастворимые и/или чувствительные к кислотам лекарственные средства и нейтрализованные кислотные полимеры
EA200600877A1 (ru) Наночастицы для доставки лекарств
TW200642704A (en) Oral drug delivery system and methods of use thereof
HK1118011A1 (zh) 透明質酸的抗腫瘤生物結合物或以化學接合方法間接地取得的衍生物,以及其製藥用途
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
BR0308486A (pt) Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga
CY1108854T1 (el) Οροδιασπειρoμενη φαρμακευτικη συνθεση ιβαβραδινης
DE602005011818D1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
DE602004021713D1 (de) Pharmazeutische formulierungen mit kurzketten-sphingolipiden und ihre verwendung
NO20076120L (no) Stabile nanopartikkelformuleringer
EA200501301A1 (ru) Ментоловые растворы лекарственных препаратов
ATE410154T1 (de) Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol